ADVERSE EFFECTS
Clinical trials for ADVERSE EFFECTS explained in plain language.
Never miss a new study
Get alerted when new ADVERSE EFFECTS trials appear
Sign up with your email to follow new studies for ADVERSE EFFECTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for transplant patients: drug combo may tame deadly immune attack
Disease control Recruiting nowThis study tests a drug called ruxolitinib for treating acute graft-versus-host disease (GVHD), a serious condition where donor cells attack the patient's body after a bone marrow transplant. About 98 adults with moderate to severe GVHD will receive either ruxolitinib alone or wi…
Matched conditions: ADVERSE EFFECTS
Phase: PHASE2 • Sponsor: John Levine • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
App aims to cut PICC line complications by putting care in patients' hands
Knowledge-focused Recruiting nowThis study tests whether a smartphone app can help patients with a PICC line (a thin tube used for long-term IV treatments at home) manage their care better. About 200 adults will use the app to track their line and report problems, with the goal of reducing complications like in…
Matched conditions: ADVERSE EFFECTS
Phase: NA • Sponsor: Fundacion Miguel Servet • Aim: Knowledge-focused
Last updated May 17, 2026 10:04 UTC